- Home
- MBOT
as 10-31-2025 10:00am EST
Microbot Medical Inc is a clinical-stage medical device company specializing in the research, design and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is focused on leveraging its robotic technologies to redefine surgical robotics while improving surgical outcomes for patients. Using its LIBERTY technological platform, the company is developing the first-ever fully disposable robot for various endovascular interventional procedures.
| Founded: | 2010 | Country: | United States |
| Employees: | N/A | City: | HINGHAM |
| Market Cap: | 184.8M | IPO Year: | N/A |
| Target Price: | $12.00 | AVG Volume (30 days): | 2.9M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.50 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.89 - $4.67 | Next Earning Date: | 11-13-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | 1107.73% |
Latest Microbot Medical Inc. News
MBOT Breaking Stock News: Dive into MBOT Ticker-Specific Updates for Smart Investing
GlobeNewswire
15 days ago
Microbot Medical® to Commercially Debut the LIBERTY® System at The Symposium on Clinical Interventional Oncology Annual Meeting
GlobeNewswire
17 days ago
Microbot Medical® Secures U.S. Based Logistics Partner to Support the Commercialization of Its LIBERTY® Endovascular Robotic System
GlobeNewswire
24 days ago
Microbot Medical Announces Final Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds
Simply Wall St.
4 months ago
Companies Like Microbot Medical (NASDAQ:MBOT) Are In A Position To Invest In Growth
GlobeNewswire
4 months ago
Microbot Medical Strengthens Global IP Portfolio with Newly Granted Patent in China
Zacks
5 months ago
Microbot Medical (MBOT) Upgraded to Buy: What Does It Mean for the Stock?
GlobeNewswire
5 months ago
Microbot Medical Continues to Strengthen Commercial Capabilities in Preparation for the anticipated Q3 2025 Launch of its LIBERTY® Endovascular Robotic System
MT Newswires
5 months ago
Microbot Medical Selected in Preliminary List for Russell Microcap Index Inclusion
Compare MBOT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MBOT Microbot Medical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.